Paper of the Year Award
ADAPT Papers of the Year
2022 - Matt Crowley, MD
Effect of a Comprehensive Telehealth Intervention vs Telemonitoring and Care Coordination in Patients With Persistently Poor Type 2 Diabetes Control: A Randomized Clinical Trial
Published in JAMA Internal Medicine
Dr. Crowley and colleagues developed an active-comparator, parallel-arm RCT to evaluate a 12-month intervention designed to address gaps in care of patients with persistently poor Type 2 diabetes mellitus control (PPDM). Their analysis found that the intervention, delivered as a series of telehealth check-ins with patients' providers, improved multiple outcomes of interest in patients with PPDM at a reasonable cost. Their findings support the high value of interim telehealth visits to monitor patients both during and after the COVID-19 pandemic.
2021 - Maren Olsen, PhD
Which patients benefit most from completing health risk assessments: comparing methods to identify heterogeneity of treatment effects?
Published in Health Services and Outcomes Research Methodology
Dr. Olsen and colleagues developed a novel predictive risk modeling (PRM) approach and used data from a behavioral intervention trial (ACTIVATE) to compare subgroup effects with those identified by model-based recursive partitioning (MoB). This work provides key context for other investigators who are interested in implementing HTE in analysis of behavioral interventions.
2020 - Will Yancy, MD
Comparison of Group Medical Visits Combined With Intensive Weight Management vs. Group Medical Visits Alone for Glycemia in Patients with Type 2 Diabetes: A Noninferiority Randomized Clinical Trial
Published in JAMA Internal Medicine
Dr. Yancy and colleagues used a non-inferiority design to compare outcomes between an intensive weight management program and a diabetes medication management program. This work is the first published study to suggest that a diet intervention is equally effective as medication intensification for glycemic control, with the added benefits of weight loss, fewer hypoglycemic events, and decreased medication use.
2019 - George Jackson, PhD
Intermediate Diabetes Outcomes in Patients Managed by Physicians, Nurse Practitioners, or Physician Assistants: A Cohort Study
Published in Annals of Internal Medicine
Dr. Jackson and colleagues used diabetes as a model to investigate whether patients with NPs or PAs as their PCPs had chronic illness outcomes different from patients seen by physicians. There were no clinically significant differences in intermediate diabetes outcomes or the control of those outcomes among patients with NP, PA, or physician PCPs. This study provides further evidence that using NPs and PAs as PCPs may represent a mechanism for expanding access to primary care while maintaining quality standards.
